申请人:ISIS Pharmaceuticals, Inc.
公开号:US20030187240A1
公开(公告)日:2003-10-02
Compositions and methods are provided for the treatment and diagnosis of diseases amenable to modulation of the production of selected proteins. In accordance with preferred embodiments, oligonucleotides and oligonucleotide analogs are provided which are specifically hybridizable with a selected sequence of RNA or DNA wherein at least one of the 2′-deoxyfuranosyl moieties of the nucleoside unit is modified. Treatment of diseases caused by various viruses and other causative agents is provided.
提供了用于治疗和诊断可调节选择蛋白质生成的疾病的组合物和方法。根据优选实施例,提供了可以与RNA或DNA的选择序列特异性杂交的寡核苷酸和寡核苷酸类似物,其中核苷酸单元的至少一个2'-脱氧呋喃糖基团被修饰。提供了治疗由各种病毒和其他致病因子引起的疾病的方法。